Stock Ratings / Financials / MPT / options

AAT (61) CBL (71) UMH (62) ALX (73) ⌘ Pro Terminal →

Medical Properties Trust Inc. (MPT) Options Positioning, Max Pain & Unusual Sweeps

Q: Is MPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Medical Properties Trust Inc. (NYSE: MPT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $2.44 (-11.27% 1D, market cap $1.46B). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, MPT ranks #963 in composite RQD confidence.

Q: How does MPT compare to AAT and CBL in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), MPT carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -6.0%. By comparison, AAT (American Assets Trust Inc.) holds a C- grade (61/100 RQD, P/E N/A, ROIC 11.3%, cap $1.37B) and CBL (CBL & Associates Properties Inc.) posts a B- grade (71/100 RQD, P/E 11.6x, ROIC 36.3%, cap $1.57B). Among the 5-stock peer group, CBL leads on earnings multiple (11.6x) while CBL leads on capital efficiency (36.3% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for MPT?

Per MPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001287865), Medical Properties Trust Inc. generated $972.0M in revenue (-2.4% YoY), -$277.0M in net income, and $230.8M in free cash flow against $15.00B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is MPT trading relative to its 50-day, 200-day, and 52-week technical levels?

MPT last traded at $2.44 (-11.27% on volume of 35,765,660 shares), positioning the stock -28.45% below its 50-day simple moving average ($3.41) and -46.49% below its 200-day simple moving average ($4.56). Across its 52-week range of $2.06 to $6.47, MPT sits at the 8.6% percentile with a 14-day RSI of 19.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.3% ($2.14 to $2.74).

Q: What is MPT's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for MPT.

$2.44 -11.27% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $2.39

Medical Properties Trust Inc. (MPT) carries a Roarable Rating of D- (Sell) with 42/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE D- • SELL / AVOID Cap $1.46B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $2.39 (-2.22%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 7/20 (D-) • 23.7% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (42/100 · D-) historically underperformed SPY in 71% of rolling 90-day windows (-7.0% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERSELL / AVOID • D-

2-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+

Each axis scored 0–20

12M PRICE TARGET CONE-7.4% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MPT)Realized 20D OHLCV Swing Band: ±12.3%

Deterministic 5-Pillar Attribution (42/100 Composite)

🔍 WHY MPT SCORES 42/100 (D-) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: SEC 10-K Forensic Risk+11/20 pts (26% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 4/9

▲ #2 Bullish Driver: Macro Regime Fit+10/20 pts (24% of score)

FRED Regime × Technicals: 9% of 52W Range • RSI-14 at 19.4 (OVERSOLD (<32))

▼ #1 Drag / Risk Factor: Whale & Options Positioning5/20 pts (-15 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-15 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade C-$3.14-4.1% Next Q

Q2 (-2Q)

Grade D$3.01-10.3% Next Q

Q3 (-1Q)

Grade D$2.70-9.6% Next Q

Current

Grade D-$2.44-7% Hist 90D α

Trajectory: C- (50) → D- (42)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a MPT Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While MPT currently carries a cautious 42/100 (D-) rating due to Whale & Options Positioning (5/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($3.41) and Max Pain ($2.56) forces dealer call-delta covering toward $6.79.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $MPT• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “MPT Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 42%NO 58%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±12.3%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (MPT)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for MPT.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MPT)

✓Walkthrough of MPT's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MPT // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -50.61%▼ SUPPORT BREAKDOWN

2026-10-30O $2.39H $2.44L $2.06C $2.44VOL 47.93M

RES: $4.37SUP: $2.68SMA50: $3.41SMA200: $4.56

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MPT Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MPT Butterfly Map → + Track MPT →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. -2.4% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MPT today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MPT. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MPT today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MPT)

Financials Rank #963 of 1096 ⚔️ AAT vs MPT Full Matrix →

1. Head-to-Head Financials Peer Comparison (MPT vs. AAT, CBL, UMH, ALX)

Industry: Real Estate Investment Trusts (172 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Medical Properties Trust Inc. (MPT) ranks #963 by composite RQD confidence (42/100, grade D-) and #498 by equity capitalization ($1.46B). Within this direct 5-issuer industry benchmark cohort, CBL leads on earnings valuation at 11.6x trailing P/E, while CBL leads on capital efficiency and profitability with 36.3% ROIC and — gross margin. ALX currently holds the highest overall quantitative score in the immediate peer group at 73/100 (B) compared with MPT at 42/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MPT ACTIVE Medical Properties Trust Inc.	D-	42/100	—	—	-6.0%	-11.27%	$1.46B	Benchmark Subject
AAT American Assets Trust Inc.	C-	61/100	—	—	11.3%	+3.19%	$1.37B	/aat-vs-mpt →
CBL CBL & Associates Properties Inc.	B-	71/100	11.6x	—	36.3%	+2.28%	$1.57B	/cbl-vs-mpt →
UMH UMH Properties Inc.	C	62/100	—	—	0.7%	+1.54%	$1.30B	/umh-vs-mpt →
ALX Alexander's Inc.	B	73/100	45.1x	—	25.9%	+0.46%	$1.27B	/alx-vs-mpt →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001287865

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Medical Properties Trust Inc. (MPT) reported GAAP revenue of $972.0M (-2.4% vs. FY2024 revenue of $995.5M , and +11.5% cumulative change since FY2023) , GAAP net income of -$277.0M, operating cash flow of $230.8M, and free cash flow of $230.8M (-6.0% YoY). On the balance sheet, MPT closed FY2025 with $15.00B in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 4/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$972.0M	-$277.0M	$230.8M	$230.8M	$15.00B	—
FY2024 (FY)	2024-12-31	$995.5M	-$2.41B	$245.5M	$245.5M	$14.29B	—
FY2023 (FY)	2023-12-31	$871.8M	-$556.5M	$505.8M	$505.8M	—	—

3. MPT Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MPT stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Medical Properties Trust Inc. (NYSE: MPT) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 42/100 at a spot price of $2.44 (-11.27% 1D, market cap $1.46B). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 11/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 9/20. Across 1096 tracked Financials issuers, MPT ranks #963 in composite RQD confidence.

How does MPT compare to AAT and CBL in the Financials sector?

Within the Financials sector (Real Estate Investment Trusts), MPT carries a Roarable D- (42/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -6.0%. By comparison, AAT (American Assets Trust Inc.) holds a C- grade (61/100 RQD, P/E N/A, ROIC 11.3%, cap $1.37B) and CBL (CBL & Associates Properties Inc.) posts a B- grade (71/100 RQD, P/E 11.6x, ROIC 36.3%, cap $1.57B). Among the 5-stock peer group, CBL leads on earnings multiple (11.6x) while CBL leads on capital efficiency (36.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MPT?

Per MPT's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001287865), Medical Properties Trust Inc. generated $972.0M in revenue (-2.4% YoY), -$277.0M in net income, and $230.8M in free cash flow against $15.00B in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MPT trading relative to its 50-day, 200-day, and 52-week technical levels?

MPT last traded at $2.44 (-11.27% on volume of 35,765,660 shares), positioning the stock -28.45% below its 50-day simple moving average ($3.41) and -46.49% below its 200-day simple moving average ($4.56). Across its 52-week range of $2.06 to $6.47, MPT sits at the 8.6% percentile with a 14-day RSI of 19.4 (OVERSOLD (<32)) and an implied next-earnings move of ±12.3% ($2.14 to $2.74).

MPT Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is MPT's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for MPT.

Direct Sub-Reports: MPT RQD Cockpit MPT 12M Forecast MPT Earnings & Move MPT Dividends & DRIP MPT Insiders & 13F MPT Whale Options MPT Profit Sankey MPT News & Why